100245-19-0

Basic information

• Product Name: 2-(4-methoxybenzyl)-2H-tetrazole-5-carbonyl chloride
• Synonyms: 2-(4-methoxybenzyl)-2H-tetrazole-5-carbonyl chloride
• CAS NO: 100245-19-0
• Molecular Weight: 252.66
• Mol File: 100245-19-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-(4-methoxybenzyl)-2H-tetrazole-5-carbonyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-methoxybenzyl)-2H-tetrazole-5-carbonyl chloride(100245-19-0)
• EPA Substance Registry System: 2-(4-methoxybenzyl)-2H-tetrazole-5-carbonyl chloride(100245-19-0)

Safety Data

• Hazardous Substances Data: 100245-19-0(Hazardous Substances Data)

Upstream product

• 824-94-2 p-methoxybenzyl chloride 
• 70978-33-5 potassium 2-(p-methoxybenzyl)tetrazole-5-carboxylate 

Downstream Products

• 70978-04-0 N-(3-acetyl-5-ethyl-2-hydroxyphenyl)-2-(4-methoxybenzyl)tetrazole-5-carboxamide 

Relevant articles and documents

METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY

The present invention provides the use of a neutral endopeptidase inhibitor, in the manufacture of a medicament for the treatment, amelioration and/or prevention of contrast-induced nephropathy. The invention also relates to the use of a compound of Formula I: wherein R1, R2, R3, R5, X, A3, B1, s and n are defined herein, for the treatment, amelioration and/or prevention of contrast-induced nephropathy. The present invention further provides a combination of pharmacologically active agents for use in the treatment, amelioration and/or prevention of contrast-induced nephropathy.

Synthesis and quantititive structure-activity relationships of antiallergic 2-hydroxy-N-1H-tetrazol-5-ylbenzamides and N-(2-hydroxyphenyl)-1H-tetrazole-5-carboxamides

-